Invivyd to Host First Quarter 2025 Financial Results and Corporate Update Conference Call on May 15, 2025
Invivyd (NASDAQ: IVVD), a biopharmaceutical company focused on protection against serious viral infectious diseases, has scheduled a conference call for Thursday, May 15, 2025, at 8:30 a.m. ET. The call will cover the company's first quarter 2025 financial results for the period ending March 31, 2025, along with recent business updates.
Analysts interested in participating in the Q&A session should join 15 minutes before the start time. The webcast will be available for replay on Invivyd's investor relations website approximately two hours after the call concludes.
Invivyd (NASDAQ: IVVD), una società biofarmaceutica specializzata nella protezione contro gravi malattie infettive virali, ha programmato una conference call per giovedì 15 maggio 2025 alle 8:30 ET. Durante la chiamata saranno presentati i risultati finanziari del primo trimestre 2025 relativi al periodo conclusosi il 31 marzo 2025, insieme agli aggiornamenti recenti sull'attività aziendale.
Gli analisti interessati a partecipare alla sessione di domande e risposte sono invitati a collegarsi 15 minuti prima dell'inizio. La webcasting sarà disponibile in replica sul sito delle relazioni con gli investitori di Invivyd circa due ore dopo la conclusione della chiamata.
Invivyd (NASDAQ: IVVD), una compañía biofarmacéutica enfocada en la protección contra enfermedades virales infecciosas graves, ha programado una conferencia telefónica para el jueves 15 de mayo de 2025 a las 8:30 a.m. ET. La llamada cubrirá los resultados financieros del primer trimestre de 2025 correspondientes al periodo finalizado el 31 de marzo de 2025, junto con actualizaciones recientes del negocio.
Los analistas interesados en participar en la sesión de preguntas y respuestas deben unirse 15 minutos antes del inicio. La retransmisión estará disponible para reproducir en el sitio web de relaciones con inversionistas de Invivyd aproximadamente dos horas después de que finalice la llamada.
Invivyd (NASDAQ: IVVD)는 심각한 바이러스 감염 질환으로부터 보호하는 데 중점을 둔 바이오제약 회사로, 2025년 5월 15일 목요일 오전 8시 30분(동부시간)에 컨퍼런스 콜을 예정하고 있습니다. 이번 콜에서는 2025년 3월 31일로 종료된 기간의 2025년 1분기 재무 결과와 최근 비즈니스 업데이트를 다룰 예정입니다.
질의응답 세션에 참여하려는 애널리스트는 시작 15분 전에 접속해 주시기 바랍니다. 컨퍼런스 콜 종료 약 2시간 후 Invivyd 투자자 관계 웹사이트에서 웹캐스트 재방송을 시청할 수 있습니다.
Invivyd (NASDAQ : IVVD), une société biopharmaceutique spécialisée dans la protection contre les maladies virales infectieuses graves, a programmé une conférence téléphonique pour le jeudi 15 mai 2025 à 8h30 ET. L'appel portera sur les résultats financiers du premier trimestre 2025 pour la période se terminant le 31 mars 2025, ainsi que sur les mises à jour récentes de l'entreprise.
Les analystes souhaitant participer à la séance de questions-réponses doivent se connecter 15 minutes avant le début. Le webcast sera disponible en replay sur le site des relations investisseurs d'Invivyd environ deux heures après la fin de l'appel.
Invivyd (NASDAQ: IVVD), ein biopharmazeutisches Unternehmen, das sich auf den Schutz vor schweren viralen Infektionskrankheiten spezialisiert hat, hat eine Telefonkonferenz für Donnerstag, den 15. Mai 2025, um 8:30 Uhr ET angesetzt. Während des Calls werden die Finanzergebnisse für das erste Quartal 2025 für den Zeitraum bis zum 31. März 2025 sowie aktuelle Geschäftsinformationen vorgestellt.
Analysten, die an der Fragerunde teilnehmen möchten, sollten 15 Minuten vor Beginn beitreten. Die Webcast-Aufzeichnung wird etwa zwei Stunden nach Ende der Telefonkonferenz auf der Investor-Relations-Website von Invivyd verfügbar sein.
- None.
- None.
WALTHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it will host a conference call on Thursday, May 15, 2025, at 8:30 a.m. ET to discuss its financial results for the first quarter ended March 31, 2025, and provide recent business highlights.
Listeners can register for the webcast via this link. Analysts wishing to participate in the question-and-answer session should use this link and are advised to join 15 minutes prior to the start time. A replay of the webcast will be available via the company’s investor relations website approximately two hours after the conclusion of the call.
About Invivyd
Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more.
Contacts:
Media Relations
(781) 208-1747
media@invivyd.com
Investor Relations
(781) 208-1747
investors@invivyd.com
FAQ
When is Invivyd (IVVD) reporting Q1 2025 earnings?
How can I listen to Invivyd's Q1 2025 earnings call?
What period will Invivyd's Q1 2025 financial results cover?
What time should analysts join Invivyd's Q1 2025 earnings call?
